Editor's Note: Debra Sherman died of cancer in April 2014. We were honored to have known her and to share her blogs about  her cancer journey with Center for Health Journalism Digital readers.

I've been with Reuters since 1994 and have covered health for the last 12 years, focusing on medical technology. I am currently based in Chicago. Before getting on the health beat (my favorite), I covered U.S. stock, commodity and deriviative markets. I also covered the British stock market in the late 1990s while working for Reuters in London.

Articles

Canine therapy, in which patients socialize with dogs to promote healing and well-being, is a well-accepted practice in medicine today. It has been shown to help people suffering from heart failure, post-traumatic stress disorder and — for those like me — cancer.

I can put up with all the inconveniences and expenses of cancer treatment. What got me was having to tell my children — Alex, who’s 14, and Stella, just 11 — that I have a particularly dangerous form of cancer. It was by far the hardest thing I’ve ever had to do.

I recently spoke with Dr. Leonard Lichtenfeld, the Deputy Chief Medical Officer for the ACS. I told him how I wished I had undergone screening earlier, thinking my cancer would have been caught before it could spread to my bones and my brain. “I would not have screened you,” he said bluntly.

The genetic tree answers a lot of questions for the patient, as well as for family who must mix their care for the stricken with an understandable concern about where the cancer came from–and who might be next.

A study of more than 300 patients suffering advanced cancer found that people who received spiritual support from religious communities tended to want aggressive end-of-life care.

As a Reuters journalist I have been writing about medical technology and health care for more than a decade. I wrote those stories objectively and never imagined any would ever apply to me. Now, I have Stage 4 lung cancer.